%0 Journal Article
%K *Cardiovascular Diseases/epidemiology/prevention & control
%K *Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology
%K *Dipeptidyl-Peptidase IV Inhibitors/therapeutic use
%K England
%K Female
%K Germany
%K Glucose
%K Humans
%K Japan
%K Middle Aged
%K Norway
%K Republic of Korea
%K Sodium
%K *Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
%K Sweden/epidemiology
%K DPP-IV inhibitor
%K SGLT2 inhibitor
%K dapagliflozin
%K diabetic nephropathy
%K heart failure
%K Observational study
%B Diabetes Obes Metab
%D 2021
%G eng
%M 32893440
%P 75-85
%R 10.1111/dom.14189
%T Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
%V 23
%2 PMC7756303
%7 2020/09/08
%@ 1462-8902 (Print)1462-8902